共 12 条
- [1] Japan's strategy for global health diplomacy: why it matters [J]. LANCET, 2013, 382 (9896) : 915 - 916
- [2] Cabinet Office, GEN OV EX REG REF CO
- [3] EVALUATING QUALITY OF MEDICAL CARE [J]. MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1966, 44 (03): : 166 - 206
- [4] The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (01): : 17 - 23
- [5] Japan Pharmaceutical Association, STUS EFF PHARM DRUG
- [6] SETSUYAKU-BAG Campaign-Investigation of Leftover Drugs Retained by Outpatients and Promotion of Proper Reuse Leftover Drugs to Reduce Medical Expenses [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2013, 133 (11): : 1215 - 1221
- [7] Ministry of Health Labour and Welfare, UN DRUGS SPL DISP DO
- [8] Nakamura K, 2014, IRYO YAKUGAKU, V40, P522, DOI DOI 10.5649/JJPHCS.40.522
- [9] The Japanese healthcare system - The issue is to solve the "tragedy of the commons "without making another [J]. BRITISH MEDICAL JOURNAL, 2005, 331 (7518): : 648 - 649
- [10] OECD, 2014, OECD REV HLTH CAR QU, DOI DOI 10.1787/9789264225817-EN